VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

EHA 2020 | Altered pathways as a biomarker for disease outcomes in CLL

Carsten Niemann, MD, PhD, of Copenhagen University Hospital, Copenhagen, Denmark, describes how the number of signaling pathways altered by driver mutations in chronic lymphocytic leukemia (CLL) impacts disease outcome. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).
Paper: https://clincancerres.aacrjournals.org/content/26/6/1507

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter